05.09.13
Ligand
1Q Revenues: $11.7 million (+107%)
1Q Earnings: $1.5 million (+32%)
Comments: Royalties were up 90% to $5.8 million driven by Promacta and new royalties from Kyprolis. Material sales were $1.5 million, up from $667,000 in 1Q12. Collaborative R&D revenues were $4.3 million, up from $1.9 million 1Q12.
1Q Revenues: $11.7 million (+107%)
1Q Earnings: $1.5 million (+32%)
Comments: Royalties were up 90% to $5.8 million driven by Promacta and new royalties from Kyprolis. Material sales were $1.5 million, up from $667,000 in 1Q12. Collaborative R&D revenues were $4.3 million, up from $1.9 million 1Q12.